Shares Investor Evening (London)

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies.
The event on 2 July 2019 in London will include:
• An opportunity for you to talk directly with the directors and ask your questions about the companies’ core strengths and their short and long-term business strategy
• Meet fellow investors and share your investing experience
• Complimentary drinks and food
More about the companies presenting:
Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Impact Healthcare REIT (IHR) are traded on the Premium Segment of the Main Market of the London Stock Exchange. Our aim is to provide shareholders with an attractive return, by investing in a diversified portfolio of UK healthcare real estate assets, in particular residential care homes.
+ more to be announced...

Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
Evening timings
18.00
Registration and coffee
18.30
Presentations
Martin Whitaker, CEO - Diurnal (DNL)
Andrew Cowley, Managing Partner - Impact Healthcare REIT (IHR)
Mahesh Patel, Managing Partner - Impact Healthcare REIT (IHR)
+ More to be announced
20.30
Drinks reception and canapés
21.30
Close

For more information, visit https://www.sharesmagazine.co.uk/events/event/shares-investor-evening-london-020719